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Abstract 
 A novel system for remote monitoring of metabolism in 
animal model is proposed in this paper.  The system is 
obtained by integrating Bio-Nano-Sensors to detect single-
metabolites, an electrochemical front-end made with off-
the-shelf components, an RF communication sub-system, 
and an antenna of new design. The system has been 
calibrated and tested for continuous monitoring of four 
different metabolites: glucose, lactate, glutamate, and 
adenosine triphosphate (ATP). Tests with animal models 
(mice) have been conducted to investigate tissue 
inflammation induced by the implanted Bio-Nano-
Sensors. The tests confirmed that our system is suitable 
and reliable for remote monitoring of single-metabolites 
in experiments with animal models. 
I. INTRODUCTION 
Genetically engineered mice are highly useful models for 
emulating human diseases and studying disease mechanisms 
as well as for testing therapeutic strategies [1]. Remote 
monitoring during the experiments assures continuous 
acquisition of data on soluble mediators in animal model. 
Remote monitoring of blood pressure in mice has been 
already demonstrated including remote powering of the 
system [2]. Although many other physiological parameters, 
e.g. the viscosity [3], may be monitored by telemetry, the big 
challenge is the monitoring of the animal model at molecular 
level. Thus, it is so important to follow in time the biomarkers 
trend related to the disease under investigation. Continuous 
monitoring of humans is already in the market for glucose [4] 
as well as for lactate. The reliability of the technology for 
glucose remote monitoring has been validated up to 8 month 
in mice [5] and up to one year in pigs [6]. The next step will 
be the extension of the technology to other relevant 
metabolites like, for example, glutamate and ATP. Glutamate 
is an important neurotransmitter usually associated with brain 
damages [7] while ATP has been very recently associated to 
regulation of adaptive immune responses [8]. Carbon 
Nanotubes have been demonstrated to enhance the sensitivity 
for exogenous [9] and endogenous [10] metabolites.  
The aim of the present paper is to propose the first telemetry 
system based on Bio-Nano-Sensors and reliable for remote 
and continuous single-metabolite monitoring of glucose, 
lactate, glutamate, and ATP in mouse models. 
 
II THE REMOTE MONITORING SYSTEM 
A. The wireless implantable system 
A wireless electrochemical monitoring system has been 
realized to assess the sensor in-vivo, as shown in Fig.1. This 
embedded system responds to the constraints linked to 
implants in animals. The materials used to build the 
packaging are biocompatible and support chemical 
sterilization process such as ethylene oxide gas or chlorine 
bleach. The wireless link allows us to control and to automate 
the measurements at distance with a laptop computer that can 
be easily brought into the operation room. 
 
B. The Implantable Body Sensor Node 
The wireless monitoring system is based on the generic 
implantable Body Sensor Node (BSN) previously used for 
rheology monitoring and already described in [3, 11]. 
 
 
 
Figure 1. The system for remote acquisitions with single-
metabolite bio-nano-sensors 
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Figure 2. Calibration curve for Glutamate detection in the 
concentration range from 0 to 2 mM 
 
C. The Electrochemical Front-End 
The novelty proposed in this paper for the remote monitoring 
system is in the electrochemical front-end. To interface the 
BSN to the electrochemical sensor a simple potentiostat 
following [12] was realized. It is based on the commercial IC 
MAX4039 (manufactured by Maxim integrated products) that 
integrates two operational amplifiers and one voltage 
reference (1.2 V). The IC is powered by the 3 V battery and 
consumes only 9 µW. The potentiostat is mounted on a 
circular Printed Circuit Board (PCB) of 7 mm in diameter, 
which is placed at the end of the BSN, just after the batteries. 
The potentiostat output is connected to the DSP analogue-to-
digital converter. Then the signal is low-pass filtered and the 
data are directly sent to the base station. A computer 
connected to the base station can display the data in real-time 
and save them for further analysis. The computer can also 
automate the measurement by enabling and disabling the 
BSN remotely. Then, the Bio-Nano-Sensor (see Section III) is 
connected to a biocompatible cable in polyurethane with 
silver coated wires that goes through the BSN housing to the 
potentiostat. 
 
III. SINGLE-METABOLITE BIO-NANO-SENSORS  
A. Chemicals 
Multi-Walled Carbon Nanotubes (MWCNT) were purchased 
in powder (90% purity) from Dropsens (Spain). Glucose 
oxidase from Aspergillus Niger (GOD, EC 1.1.3.4, 129.9 
units/mg solid) lactate oxidase from Pediococcus species 
(LOD, EC 1.13.12.4,   20 units/mg solid), hexokinase (HEX) 
type 3 from Baker Yeast, D-(+)-glucose, lithium L-lactate, 
and L-glutamic acid were purchased from Sigma-Aldrich 
(Switzerland) as lyophilized powder. Glutamate oxidase from 
Streptomyces species (GlOD, EC 1.4.3.11, 25 units) was 
supplied from Yamasa Co. (Japan). All the proteins were 
dissolved in Phosphate Buffer Solution (PBS) 0.01 M at pH 
7.4, while the other reagents were dissolved in Milli-Q. 
 
B. Screen-Printed Electrodes 
Experiments were carried out using screen-printed electrodes 
(SPE) from Dropsens (Spain).  
 
Figure 3. Calibration curve for ATP detection in the 
concentration range from 0 to 1.4 mM 
 
Working and counter electrodes are made of graphite, while 
the reference electrode is in Ag/AgCl. The total area of the 
cell is around 22 mm
2
, with a working electrode of 4 mm in 
diameter. 
 
C. Preparation of the Bio-Nano-Sensors  
A 40 µl volume of the MWCNT-chloroform solution was 
deposited by drop casting (5 µl each time) onto the working 
electrode and dried. Then, 20 µl of the enzyme probe were 
dropped onto the working electrode and stored overnight at 
+4 ºC, in order to allow the adsorption of the proteins onto 
the electrode surface. Glucose oxidase was prepared at a 
concentration of 15 mg/ml, lactate oxidase at 125 mg/ml, and 
glutamate oxidase at a concentration of 250 units/ml. For the 
measure of the ATP, instead, GOD and HEX were mixed in a 
1:1 ratio to obtain a solution at pH 7.4 with 15 mg/ml of each 
protein. 20 !l of the solution were then drop cast onto the 
working electrode, and let dry at 4ºC overnight. The 
electrodes were rinsed out with Milli-Q the day after the 
deposition and conditioned for 10 minutes at constant 
potential (+650 mV) before the first use. 
 
D. Calibration Curves and Telemetry Acquisitions 
For calibration and investigation of the detection limit, 
electrodes were dipped into the PBS with a volume of 25 ml 
under stirring conditions. The electrochemical response of 
electrodes is investigated by chronoamperometries under 
aerobic conditions. The Bio-Nano-Sensors calibration has 
been done with electrochemical measurements acquired with 
the lab-electrochemical-station Versastat 3 potentiostat 
(Princeton Applied Technologies). The telemetry acquisitions 
in time have been instead acquired by using the developed 
telemetry system described in the previous session. 
 
IV. IN-VITRO AND IN-VIVO TESTS 
 
A. Calibration for Glucose, Lactate, and Glutamate 
Oxidases are enzymes that catalyze the transformation of 
metabolite (X) in metabolism product (Xp) by following the 
equation: 
222 OHXOX P
XOD + →+ .    (1) 
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 The metabolite X is glucose, lactate, and glutamate, which are 
catalyzed by the glucose-oxidase (GOD), the lactate-oxidase 
(LOD), and the glutamate-oxidase (GLOD), respectively. The 
reaction (1) produces the hydrogen peroxide (H2O2) that may 
be oxidized: 
 
−++ ++ → eOHOOH mV 422 22
650
22        (2) 
 
or reduced: 
OHeHOH mV 2
1540
22 222  →++
+−+
       (3) 
at the interface with our electrodes. Equations (2) and (3) are 
two different redox reactions, the first enabled at the 
electrodes interface with a typical potential of +650 mV, 
while the second with typical potential of +1540 mV. Of 
course, these potentials also depend on the metal of the 
electrodes. In presence of oxygen, reaction (2) is the most 
common used. So, for our Bio-Nano-Sensors we worked at 
+650 mV by following the redox of equation (2). Figs. 2, and 
3, report the obtained calibration curve for two different 
metabolites. The good sensitivity and the ranges of 
concentrations are reported in Table I. 
 
B. Calibration for ATP 
In the case of the ATP monitoring, our Bio-Nano-Sensor 
consists of two co-immobilized enzymes: glucose oxidase 
and hexokinase. Both enzymes are sensitive to glucose, but 
with a different catalytic mechanism: 
 
222 OHAcidGluconicDOseGlucoD
GOD +− →+−    (4) 
ADPPoseGlucDATPoseGlucD HEX +−−− →+− 6 (5) 
 
In presence of ATP, the hexokinase competes with the 
glucose oxidase for the substrate, and the quantity of 
hydrogen peroxide produced in the reaction (4) is 
proportionally decreased by the glucose consumption in the 
reaction (5). Therefore, the ATP is detected by a decreasing 
of the current registered in the redox reaction (2). Fig. 3 
reports the obtained calibration curve for the ATP detection 
and it demonstrates a good sensitivity in the reported ranges 
of concentrations. 
 
 
Figure 4. Continuous monitoring of glucose with the single-
metabolite remote system and a glucose Bio-Nano-Sensor 
 
Metabolite Sensitivity  Range 
Glucose 299 nA/µM mm
2
 0.5-4 mM 
Lactate 446 nA/µM mm
2
 0.5-2.5 mM 
Glutamate 40 nA/µM mm
2
 0.5-2 mM 
ATP 34 pA/µM mm
2
 200-1400 µM 
Table I: sensitivity and range of the Bio-Nano-Sensors 
 
C. Telemetry Acquisitions 
The metabolite is kept by the enzymes, transformed, and then 
released in all the reactions involving oxidases and 
hexokinase. This feature of reactions (1), (4), and (5) enables 
continuous monitoring and acquisition over time of current 
variation as proportionally related to the concentration of the 
monitored metabolites. Fig. 4 shows the continuous 
monitoring of glucose over a time frame of 35 minutes, while 
Fig. 5 shows the continuous monitoring over a time frame of 
16 minutes in the case of Lactate. Similarly, continuous 
monitoring of glutamate and ATP has been registered. 
 
D. Tests with Animal Models 
To check whether the Nano-Bio-Sensors has any influence on 
tissue homeostasis at the site of implantation, we monitored 
inflammatory reaction in vivo in air pouches in mice (see Fig. 
6) in which the Nano-Bio-Sensors were implanted. The air 
pouch is generated by subcutaneous injection of sterile air 
into the back of a mouse. The resulting subcutaneous cavity 
has a diameter of around 1.5 cm and a height of 0.5 cm. The 
air pouch does not induce any relevant reaction of the tissue 
and provides an environment in which studying localized 
inflammatory phenomena by different stimuli, including the 
introduction of a Bio-Nano-Sensor. To study the impact of 
the implant, we inserted the sensor into the air pouch and 
analyzed the ATP concentration and neutrophils infiltration at 
day 7 after implantation. ATP is the source of energy for the 
cell. It is present at high concentration inside cells but 
virtually absent in extracellular fluids. Cell damage, such as 
the one taking place at inflammatory sites, determines the 
efflux of ATP from the cells and its appearance in the 
extracellular fluid, making it a so-called danger-associated 
molecular pattern. 
 
 
Figure 5. Continuous monitoring of lactate with the single-
metabolite remote system and a lactate Bio-Nano-Sensor 
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Figure 6. The air pouch model in mice used in this paper to 
test the inflammatory behaviour of the monitoring implants 
 
Neutrophils constitute around 50-70% of our circulating 
white blood cells and extravasate from blood vessels at 
inflammatory sites. Therefore, their presence and number is 
an important parameter to score inflammatory reactions. We 
analyzed these two parameters of inflammation in different 
experimental conditions. The ATP concentration in the 
subcutaneous microenvironment is not affected by suture. 
Some increase in neutrophils infiltration is detected by more 
invasive procedures such as performing the hole for 
implanting the biochip or the implantation of our Nano-Bio-
Sensors. ATP levels and neutrophils increased to a similar 
extent by LPS (bacterial lipopolysaccharide) injection, 
confirming the limited inflammation associated with sensor 
implantation (Fig. 7). Nevertheless, the level of ATP induced 
by the implant (from 20 to 60 nM depending on different 
implanted sensors) is largely below the targeted range of 
hundreds of µM for ATP concentrations found in cell 
signaling [8] and relevant for anticancer treatments [13].  
 
VI. CONCLUSION 
A novel system for remote monitoring of metabolism at 
molecular level in translational research made with animal 
models has been proposed in the paper. The new proposed 
system integrates Bio-Nano-Sensors with electrochemical 
front-end for the detection, a proper transceiver, battery for 
the powering, and a novel antenna. The Bio-Nano-Sensors are 
suitable for continuous monitoring of glucose, lactate, 
glutamate, and ATP (four highly relevant molecules of the 
human metabolism). Good sensitivities were provided by 
carbon nanotubes used as enhancers of the electrons transfer 
between the probe proteins and the sensors electrode. The 
electrochemical front-end has been built by using out-of-the-
shelf components. The low-power transceiver and the antenna 
were especially designed for prolongation of the implantation. 
With the embedded non-rechargeable batteries exhibiting a 
total energy of 600 J, the system can be powered in stand-by 
for over 9 years. The tests for continuous monitoring, 
wireless communications, and biocompatibility demonstrated 
the feasibility of this technology for translational research in 
biomedical field with mouse models. Our in-vivo tests 
demonstrated mild pro-inflammatory potential at implantation 
site, enabling the exploitation of the proposed system for in-
vivo monitoring. 
 
 
Figure 7. Tests of inflammation in the mouse induced by the 
implanted Bio-Nano-Sensor and the wear remote system. 
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